TY  - JOUR
AU  - Ribera, Josep-Maria
AU  - Morgades, Mireia
AU  - Montesinos, Pau
AU  - Tormo, Mar
AU  - Martínez-Carballeira, Daniel
AU  - González-Campos, José
AU  - Gil, Cristina
AU  - Barba, Pere
AU  - García-Boyero, Raimundo
AU  - Coll, Rosa
AU  - Pedreño, María
AU  - Ribera, Jordi
AU  - Mercadal, Santiago
AU  - Vives, Susana
AU  - Novo, Andrés
AU  - Genescà, Eulàlia
AU  - Hernández-Rivas, Jesús-María
AU  - Bergua, Juan
AU  - Amigo, María-Luz
AU  - Vall-Llovera, Ferran
AU  - Martínez-Sánchez, Pilar
AU  - Calbacho, María
AU  - García-Cadenas, Irene
AU  - Garcia-Guiñon, Antoni
AU  - Sánchez-Sánchez, María-José
AU  - Cervera, Marta
AU  - Feliu, Evarist
AU  - Orfao, Alberto
AU  - PETHEMA Group, Spanish Society of Hematology
PY  - 2020
DO  - 10.1002/cam4.2814
UR  - http://hdl.handle.net/10668/15048
T2  - Cancer medicine
AB  - Pediatric-based or -inspired trials have improved the prognosis of adolescents and young adults (AYA) with Philadelphia chromosome-negative (Ph-neg) acute lymphoblastic leukemia (ALL). This study reports the results of treatment of the ALLRE08 trial,...
LA  - en
KW  - acute lymphoblastic leukemia
KW  - adolescents and young adults
KW  - pediatric treatment
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Clinical Trials as Topic
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Neoplasm Recurrence, Local
KW  - Neoplasm, Residual
KW  - Philadelphia Chromosome
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Prognosis
KW  - Remission Induction
KW  - Survival Rate
KW  - Young Adult
TI  - A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
TY  - research article
VL  - 9
ER  -